News / Taiwan / economic_daily
Taiwan Stocks Face Volatility as Nvidia Earnings and Fed Policy Loom; Pei-Er Biomedical Hits Record High
Health Technology · Biotechnology · economic_daily · 2026-08-25
2059, 3231, 5274, 6446, 6949
Taiwan stocks retreated as investors braced for Nvidia's earnings and Fed commentary, while biotech firm Pei-Er Biomedical bucked the trend to reach a new record.
What Happened
Market Volatility: The Taiwan stock market experienced significant intraday volatility, briefly dipping below the monthly moving average as selling pressure intensified. High-priced stocks faced downward pressure, with industry leader Aspeed falling below its six-month moving average.
Macroeconomic Uncertainties: Investors are cautious ahead of Nvidia's upcoming quarterly results and the Federal Reserve's annual Jackson Hole symposium. Persistent concerns over high U.S. Treasury yields continue to weigh on market sentiment despite government efforts to manage long-term debt.
Biotech Resilience: Amid the broader market decline, capital has rotated into defensive sectors including biotechnology and shipping. Pei-Er Biomedical stood out as a notable performer, surging over 6% to reach a new all-time high above 1,300 TWD.
Company Development: Pei-Er Biomedical specializes in immune cell therapies and has successfully completed Phase II clinical trials for its CAR-T agent, PL001. The company is currently seeking regulatory approval with the goal of launching the product by early next year.